FDA’s updated standards remove an unnecessary barrier to testing Alzheimer’s drugs – STAT

March 5, 2018 by  
Filed under Alzheimers News

Sponsored By

STAT
FDA's updated standards remove an unnecessary barrier to testing Alzheimer's drugs
STAT
fter years of relying on outdated standards for evaluating new drugs for Alzheimer's and other neurologic diseases, the FDA is finally modernizing its approach 1. This is good news for researchers working to develop much-needed medications for these
Aerobic exercise slows cognitive decline in Alzheimer's diseaseARY NEWS

all 2 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*